Access to medicines

The Government and Farmaindustria renew the Agreement for Sustainability, Access and Innovation

The Agreement, which will remain in effect throughout 2018, aims to facilitate patient access to therapeutic innovations under equitable conditions and ensure the sustainability of the National Health System
 

The European biomedical industry urges the United Kingdom and the EU to protect patients’ access to medicines before Brexit

The associations that represent the European and British biomedical industry insist on the importance of ensuring cooperation between the United Kingdom and the European Union in terms of pharmaceutical regulation
 

The Government and FARMAINDUSTRIA renew the Agreement for Sustainability, Access and Innovation

The agreement is the result of a sustained dialogue and positive experience from the Protocol signed in 2015 and will be in force throughout 2017
 

EFPIA Statement on the UN HLP Report on Access to Medicines

 
Download document

© 2020 FarmaIndustria All rights reserved